In this study, adenoviral-mediated endogenous expression of (m) CD40L activated the CD40/CD40L checkpoint and improved dendritic cells-mediated cytotoxicity of effector cells against cholangiocarcinoma, pancreas carcinoma and colorectal carcinoma in vitro. This evidence concerns the gene CD40 and colorectal carcinoma.